You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Pelvic exenteration is a viable surgical option for advanced pelvic cancers, offering curative potential and effective palliation for symptomatic patients. This procedure demonstrated a low 30-day mortality and a 33% 5-year survival rate in selected cases.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: